SHINGRIX POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE

Glaxosmithkline Biologicals🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9f18859bb1fe8aeb
Drug Cima Aemps Name: SHINGRIX POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE
Register Number: 1181272001
Holder Company Name: Glaxosmithkline Biologicals
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-biologicals
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2020-10-16
Dosage Form: POLVO Y SUSPENSIÓN PARA SUSPENSIÓN INYECTABLE
Dose: 50 microgramos
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline Biologicals
Company Detail Path: /organization/glaxosmithkline-biologicals

ANTIGENO RECOMBINANTE DE LA GLICOPROTEINA E (GE) DEL VIRUS DE LA VARICELA ZOSTER (VVZ)

50 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 16, 2020

Approval ID

9f18859bb1fe8aeb

Type

Standard